Should you be as excited as the analysts who think these stocks are two-baggers in the making?
News & Analysis: MannKind Corporation
Shares rise after the company receives some praise from a pair of Wall Street analysts.
MNKD earnings call for the period ending March 31, 2019.
MNKD earnings call for the period ending December 31, 2018.
Shares jumped after the company reported upbeat fourth-quarter results. Here's what investors need to know.
Shares tumble after the biopharma raises capital from a dilutive common-stock offering.
The company has completed its planned transaction with United Therapeutics.
A new collaboration agreement breathed life into the troubled manufacturer of inhaled insulin powder.
Here's the full story of how this biopharma got to where it is today.
A new collaboration is funneling tens of millions of dollars onto the diabetes company’s balance sheet.